Canine demodicosis: The relationship between response to treatment of generalised disease and markers for inflammation and oxidative status

Veterinary Dermatology

Volumn 25, Issue 2, 2014, Pages

  Martínez Subiela, Silvia ^a   Bernal, Luis J ^a   Tvarijonaviciute, Asta ^a   Garcia Martinez, Juan D ^a   Tecles, Fernando ^a   Cerón, Jose J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; BIOLOGICAL MARKER; IVERMECTIN;

ANIMAL; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DOG; DOG DISEASES; FEMALE; INFLAMMATION; MALE; METABOLISM; MITE INFESTATIONS; OXIDATIVE STRESS; PHYSIOLOGY; VETERINARY;

ANIMALS; ANTIPARASITIC AGENTS; BIOMARKERS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; INFLAMMATION; IVERMECTIN; MALE; MITE INFESTATIONS; OXIDATIVE STRESS;

EID: 84897043325     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12108     Document Type: Article

References (33)

1. Gortel K. Update on canine demodicosis. Vet Clin North Am Small Anim Pract 2006; 36: 229-241.
2. Mueller RS, Bensignor E, Ferrer L et al. Treatment of demodicosis in dogs: 2011 clinical practice guidelines. Vet Dermatol 2012; 23: 86-96, e20-e21.
3. Plant JD, Lund EM, Yang M. A case-control study of the risk factors for canine juvenile-onset generalized demodicosis in the USA. Vet Dermatol 2011; 22: 95-99.
4. Paradis M. New approaches to the treatment of canine demodicosis. Vet Clin North Am Small Anim Pract 1999; 29: 1425-1436.
5. Mueller RS. Treatment protocols for demodicosis: an evidence-based review. Vet Dermatol 2004; 15: 75-89.
6. ® (Bayer Animal Health) with ivermectin. Vet Dermatol 2009; 20: 447-455.
7. Lemarie S. Canine demodicosis. Comp Cont Educ Pract Vet 1996; 18: 354-368.
8. Scott DW, Miller WH, Griffin CE. Parasitic skin diseases. In: Muller and Kirk's Small Animal Dermatology, Philadelphia: W.B. Saunders Co., 2001; 207-273.
9. Eckersall PD, Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet J 2010; 185: 23-27.
10. Cerón J, Eckersall PD, Martínez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 2005; 34: 85-99.
11. Ulutas B, Ural K, Ulutas AP. Acute phase response with special reference to C-reactive protein in dogs with generalized demodicosis. Acta Sci Vet 2011; 39: 1-5.
12. Santra A, Maiti A, Chowdhury A et al. Oxidative stress in liver of mice exposed to arsenic contaminated water. Indian J Gastroenterol 2000; 19: 152-155.
13. Okayama Y. Oxidative stress in allergic and inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005; 4: 517-519.
14. Dimri U, Ranjan R, Kumar N et al. Changes in oxidative stress indices, zinc and copper concentrations in blood in canine demodicosis. Vet Parasitol 2008; 154: 98-102.
15. Murata H, Shimada N, Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J 2004; 168: 28-40.
16. Tecles F, Spiranelli E, Bonfanti U et al. Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog. J Vet Intern Med 2005; 19: 865-870.
17. Martinez-Subiela S, Strauss-Ayali D, Cerón JJ et al. Acute phase protein response in experimental canine leishmaniasis. Vet Parasitol 2011; 180: 197-202.
18. Mylonakis ME, Ceron JJ, Leontides L et al. Serum acute phase proteins as clinical phase indicators and outcome predictors in naturally occurring canine monocytic ehrlichiosis. J Vet Intern Med 2011; 25: 811-817.
19. Heidarpour M, Soltani S, Mohri M et al. Canine visceral leishmaniasis: relationships between oxidative stress, liver and kidney variables, trace elements, and clinical status. Parasitol Res 2012; 111: 1491-1496.
20. Mueller RS, Bettenay SV. A proposed new therapeutic protocol for the treatment of canine mange with ivermectin. J Am Anim Hosp Assoc 1999; 35: 77-80.
21. Ristic Z, Medleau L, Paradis M et al. Ivermectin for treatment of generalized demodicosis in dogs. J Am Vet Med Assoc 1995; 207: 1308-1310.
22. Fondati A. Efficacy of daily oral ivermectin in the treatment of 10 cases of generalized demodicosis. Vet Dermatol 1996; 7: 99-104.
23. Delayte EH, Otsuka M, Larsson CE et al. Efficacy of systemic macrocyclic lactones (ivermectin and moxidectin) for the treatment of generalized canine demodicosis. Arq Bras Med Vet Zootec 2006; 58: 31-38.
24. Ginel PJ, Lucena R, Gutiérrez PL. Tratamiento de la demodicosis canina generalizada con dosis reducidas de ivermectina oral. Clín Vet Peq Anim 1998; 18: 26-33.
25. Gentilini F, Mancuni D, Dondi F et al. Validation of a human immunoturbidimetric assay for measuring canine C-reactive protein. Vet Clin Pathol 2005; 34(Suppl. 1): 318 (abstract).
26. Martínez-Subiela S, Cerón JJ. Validation of commercial assays for the determination of haptoglobin, C-reactive protein and serum amyloid A in dogs. Arch Med Vet 2005; 37: 61-66.
27. Tecles F, Martinez-Subiela S, Bernal LJ et al. Use of whole blood for spectrophotometric determination of cholinesterase activity in dogs. Vet J 2000; 160: 242-249.
28. Tvarijonaviciute A, Tecles F, Caldin M et al. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. Am J Vet Res 2012; 73: 34-41.
29. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
30. Camkerten I, Sahin T, Borazan G et al. Evaluation of blood oxidant/antioxidant balance in dogs with sarcoptic mange. Vet Parasitol 2009; 16: 106-109.
31. Cerón JJ, Caldin M, Martinez-Subiela S. Proteínas plasmáticas. In: Cerón JJ, ed. Análisis Clínicos en Pequeños Animales, Buenos Aires: Inter-Médica 2013; 91-104.
32. Blanceil Y, Delaroche O. Diminution de láctivité de la cholinestérase plasmatique au cours des infections bactérienes sévères: comparaison avec celle observée en cas de cirrhose grave. Ann Fr Anesth Reanim 1996; 15: 220-222.
33. Tvarijonaviciute A, Kocaturk M, Cansev M et al. Serum butyrylcholinesterase and paraoxonase 1 in a canine model of endotoxemia: effects of choline administration. Res Vet Sci 2012; 93: 668-674.